Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,141.70
(
0.05%
)
US TECH 100
26,215.20
(
0.04%
)
Dow Jones
49,492.34
(
0.00%
)
Brent Oil
98.55
(
1.89%
)
Bitcoin
78,116.72
(
-0.16%
)
News Focus
News Focus
Post# of 445438
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Hike

Send PM Follow Ignore
Followers 29
Posts 1939
Boards Moderated 0
Alias Born 01/11/2011

Hike

Re: AJSails post# 112694

Thursday, 06/12/2014 1:27:04 PM

Thursday, June 12, 2014 1:27:04 PM

Post# of 445438
Purdue Pharma completed a late-stage trial of its extended-release--and abuse-deterrent--formulation of hydrocodone bitartrate earlier this year and filed for FDA approval on April 30. Observers say that, if Purdue is successful, the FDA could force Zogenix to pull Zohydro, which doesn't include tamper-resistant features.

Read more: Chicago sues J&J, Purdue, Endo, Actavis, Teva over opioid marketing - FiercePharma http://www.fiercepharma.com/story/chicago-sues-jj-purdue-endo-actavis-teva-over-opioid-marketing/2014-06-03#ixzz34RlD4VcB
Subscribe at FiercePharma

"This is our year!"

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ELTP News
More ELTP News